BPX-601 CAR T-Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BPX-601 CAR T-Cell Therapy, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread [Phase 1]